Healthcare provider profile · identity verified

Jeffrey D Wartman, M.D.

Internal Medicine · RIVERVIEW, FL · NPI 1295730414

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	172
Amlodipine Besylate	Amlodipine Besylate	451	117
Metformin Hcl	Metformin Hcl	332	88
Lisinopril	Lisinopril	331	93
Levothyroxine Sodium	Levothyroxine Sodium	284	79
Hydrochlorothiazide	Hydrochlorothiazide	282	77
Losartan Potassium	Losartan Potassium	278	74
Rosuvastatin Calcium	Rosuvastatin Calcium	199	56
Metoprolol Succinate	Metoprolol Succinate	193	56
Tamsulosin Hcl	Tamsulosin Hcl	158	42
Gabapentin	Gabapentin	157	43
Alprazolam	Alprazolam	151	37
Omeprazole	Omeprazole	149	41
Simvastatin	Simvastatin	143	41
Pantoprazole Sodium	Pantoprazole Sodium	142	40
Potassium Chloride	Potassium Chloride	131	42
Alendronate Sodium	Alendronate Sodium	127	39
Trazodone Hcl	Trazodone Hcl	117	35
Pravastatin Sodium	Pravastatin Sodium	115	34
Escitalopram Oxalate	Escitalopram Oxalate	109	29
Clopidogrel	Clopidogrel Bisulfate	106	25
Allopurinol	Allopurinol	102	26
Finasteride	Finasteride	102	30
Carvedilol	Carvedilol	99	31
Atenolol	Atenolol	95	30
Eliquis	Apixaban	93	21
Duloxetine Hcl	Duloxetine Hcl	89	22
Famotidine	Famotidine	89	26
Sertraline Hcl	Sertraline Hcl	89	20
Furosemide	Furosemide	81	24
Zolpidem Tartrate	Zolpidem Tartrate	80	20
Glipizide Er	Glipizide	77	18
Metoprolol Tartrate	Metoprolol Tartrate	72	25
Albuterol Sulfate Hfa	Albuterol Sulfate	70	26
Ramipril	Ramipril	69	18
Nifedipine Er	Nifedipine	65	19
Citalopram Hbr	Citalopram Hydrobromide	63	15
Bupropion Hcl Sr	Bupropion Hcl	62	16
Donepezil Hcl	Donepezil Hcl	61	21
Synthroid	Levothyroxine Sodium	61	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	17
Farxiga	Dapagliflozin Propanediol	60	17
Fluoxetine Hcl	Fluoxetine Hcl	60	17
Fluticasone Propionate	Fluticasone Propionate	60	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	59	58
Jardiance	Empagliflozin	59	16
Metformin Hcl Er	Metformin Hcl	59	17
Paroxetine Hcl	Paroxetine Hcl	51	12
Valsartan	Valsartan	50	14
Glimepiride	Glimepiride	49	14
Xarelto	Rivaroxaban	49	12
Warfarin Sodium	Warfarin Sodium	48	12
Montelukast Sodium	Montelukast Sodium	47	14
Bumetanide	Bumetanide	46	12
Januvia	Sitagliptin Phosphate	46	15
Prednisone	Prednisone	46	28
Lorazepam	Lorazepam	45	11
Spironolactone	Spironolactone	44	17
Meloxicam	Meloxicam	43	suppressed
Mounjaro	Tirzepatide	43	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	43	37
Memantine Hcl	Memantine Hcl	41	13
Buspirone Hcl	Buspirone Hcl	39	13
Benazepril Hcl	Benazepril Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	35	11
Chlorthalidone	Chlorthalidone	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	29
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Clonazepam	Clonazepam	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Nitroglycerin	Nitroglycerin	28	17
Ozempic	Semaglutide	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Procto-Med Hc	Hydrocortisone	25	suppressed
Glipizide	Glipizide	24	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Klor-Con 10	Potassium Chloride	23	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Naproxen	Naproxen	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Invokana	Canagliflozin	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Silodosin	Silodosin	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Cefdinir	Cefdinir	16	13
Celecoxib	Celecoxib	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Fenofibrate	Fenofibrate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Colchicine	Colchicine	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error